Torrent Pharmaceuticals Q4FY16 consolidated net profit clocks three-fold jump yoy to Rs.357 crore : Estimates Mixed

India Infoline News Service | Mumbai | May 23, 2016 18:15 IST

The company’s consolidated revenue stood at Rs. 1,499 crore, up 29.9% yoy but down 2.6% qoq.

Torrent Pharmaceuticals, Ahmedabad-based and one of India's largest pharma company, reported consolidated net profit of Rs. 357 crore for the quarter ended March 31, 2016, registering growth of 174.62% yoy and 2.59% qoq. The company’s revenue stood at Rs. 1,499 crore, up 29.9% yoy but down 2.6% qoq.

Its consolidated core operating profit of Rs. 484 crore for the quarter, clocked growth of 198.77% yoy but decline of 21.04% qoq. Operating profit margin for the current quarter at 32.29% expanded by 1825 bps yoy but contracted by 754 bps qoq.

For the year ended March 31, 2016, the company reported consolidated net profit of Rs. 1,722 crore, growing by 129.29% yoy. Its consolidated revenue for the period stood at Rs. 6,676 crore, registering growth of 43.48% yoy.

Torrent Pharmaceuticals Ltd's core operating profit stood at Rs. 2,720 crore, recording growth of 166.67% yoy. Operating margin for the current period at 39.19% expanded by 1727 bps yoy.

On standalone basis,Torrent Pharmaceuticals Ltd, reported standalone net profit of Rs. 121 crore for the quarter ended March 31, 2016, registering growth of 17.48% yoy and 45.78% qoq. The company’s revenue stood at Rs. 986 crore, up 9.92% yoy but down 2.47% qoq.

Its standalone core operating profit of Rs. 216 crore for the quarter, clocked growth of 47.95% yoy but decline of 30.77% qoq. Operating profit margin for the current quarter at 21.91% expanded by 563 bps yoy but contracted by 895 bps qoq.

For the year ended March 31, 2016, the company reported standalone net profit of Rs. 1,763 crore, growing by 182.99% yoy. Its standalone revenue for the period stood at Rs. 5,429 crore, registering growth of 56.19% yoy.

Torrent Pharmaceuticals Ltd's core operating profit stood at Rs. 2,627 crore, recording growth of 211.26% yoy. Operating margin for the current period at 44.32% expanded by 2004 bps yoy.

Result Highlights: (Rs. in crore)

Reported Results IIFL Estimates Variance (%)
Consolidated Revenue 1499 1535 [2.35]
Consolidated Net Profit 357 442 [19.23]

Consolidated EPS for the quarter stood at Rs. 21.13.

Bloomberg estimated the company’s consolidated net profit at Rs. 353.31 crore.

Stock Commentary:

Torrent Pharmaceuticals Ltd is currently trading at Rs. 1396.4, up by 40.5 points or 2.99% from its previous closing of Rs. 1355.9 on the BSE.

The scrip opened at Rs. 1368 and has touched a high and low of Rs. 1404 and Rs. 1365.15 respectively. So far 135871(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 22944.54 crore.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1720 on 01-Sep-2015 and a 52 week low of Rs. 1172.2 on 01-Jun-2015. Last one week high and low of the scrip stood at Rs. 1417.95 and Rs. 1250.85 respectively.

The promoters holding in the company stood at 71.25 % while Institutions and Non-Institutions held 17.78 % and 10.98 % respectively.

The stock is currently trading below its 200 DMA.



***Note: This is a NSE Chart

 

Advertisements

  • Get your free IIFL Demat & Trading A/c now...Click here
  • Get IIFL express personal loan disbursal in just 8* hours...Know More
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.